Sort
21,281 grants matching “influenza”
Biodefense/Emerging Infection Vaccine Studies
$851,944Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
ARRA: Development of Universal Influenza Assays
$851,102Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Enhanced Oral Vaccine Delivery Vehicle
$850,927Sean N Tucker · Vaxart, Inc. · R44 · FY2010 · AI
VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE
$850,538Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2010 · RR
Containing Bioterrorist and Emerging Infectious Diseases
$850,223Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2009 · GM
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections
$850,154Kevin S Harrod · University Of Alabama At Birmingham · R01 · FY2018 · AI
Proteomics, Metabolomics and Lipidomics
$850,065Richard D Smith · University Of Wisconsin-Madison · U19 · FY2017 · AI
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactions
$849,692Geert-Jan Boons · University Of Georgia · R01 · FY2025 · AI
Control Systems Governing Short vs Longterm Humoral & Cellular Immunity
$849,631Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2012 · AI
Influenza pathogenesis in pregnancy
$849,396Kristina M Adams Waldorf · University Of Washington · R01 · FY2022 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$849,241Walter A. Orens · Emory University · N01 · FY2018 · AI
Analysis of Host-Pathogen Interactions
$849,013Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
STRENGHTENING & INTEGRATING SURVEILLANCE & RESPONSE TO SEASONAL INFLUENZA
$849,000Pushpa Wijesinghe · World Health Organization · U51 · FY2013 · IP
Broad spectrum inhibitors of paramyxovirus envelope proteins
$848,745Anne Moscona · Columbia University Health Sciences · R01 · FY2023 · AI
Automated Near-Patient Molecular Diagnostics and Discrimination of Seasonal Infl
$848,585Shuqi Chen · Iquum, Inc. · R44 · FY2011 · AI
Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors
$848,532Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2019 · AI
Preclinical development of an immunomodulatory agent capable of mitigating influenza related hypercytokinemia
$848,308Jodi K Craigo · Cytoagents, Inc. · R44 · FY2020 · AI
Production of Non-Egg grown Influenza Vaccines
$848,254Novavax, Inc. · UC1 · FY2000 · AI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
$848,166Christopher B Fox · Access To Advanced Health Institute · R01 · FY2020 · AI
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy
$847,917Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R56 · FY2021 · AI
Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry
$847,772Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Immunobiology of Lung Injury and Fibrosis
$847,613Bethany B. Moore · University Of Michigan At Ann Arbor · R35 · FY2019 · HL
Studies of IGHV Germline Gene Polymorphism, Utilization & Shifting for Seasonal Influenza Vaccine Induced Broadly Neutralizing Antibody Responses
$847,609Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2018 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$847,458Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2022 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$847,458Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2023 · AI